QQQ   306.18 (-1.78%)
AAPL   154.50 (+2.44%)
MSFT   258.35 (-2.36%)
META   186.53 (-1.19%)
GOOGL   104.78 (-2.75%)
AMZN   103.39 (-8.43%)
TSLA   189.98 (+0.91%)
NVDA   211.00 (-2.81%)
NIO   11.19 (-6.44%)
BABA   106.33 (-3.11%)
AMD   86.09 (-2.51%)
T   19.83 (-2.22%)
F   13.23 (-7.61%)
MU   62.41 (-1.20%)
CGC   2.92 (-7.01%)
GE   81.96 (-2.36%)
DIS   110.71 (-2.21%)
AMC   6.08 (+0.00%)
PFE   44.06 (-0.63%)
PYPL   85.52 (-1.66%)
NFLX   365.90 (-0.27%)
QQQ   306.18 (-1.78%)
AAPL   154.50 (+2.44%)
MSFT   258.35 (-2.36%)
META   186.53 (-1.19%)
GOOGL   104.78 (-2.75%)
AMZN   103.39 (-8.43%)
TSLA   189.98 (+0.91%)
NVDA   211.00 (-2.81%)
NIO   11.19 (-6.44%)
BABA   106.33 (-3.11%)
AMD   86.09 (-2.51%)
T   19.83 (-2.22%)
F   13.23 (-7.61%)
MU   62.41 (-1.20%)
CGC   2.92 (-7.01%)
GE   81.96 (-2.36%)
DIS   110.71 (-2.21%)
AMC   6.08 (+0.00%)
PFE   44.06 (-0.63%)
PYPL   85.52 (-1.66%)
NFLX   365.90 (-0.27%)
QQQ   306.18 (-1.78%)
AAPL   154.50 (+2.44%)
MSFT   258.35 (-2.36%)
META   186.53 (-1.19%)
GOOGL   104.78 (-2.75%)
AMZN   103.39 (-8.43%)
TSLA   189.98 (+0.91%)
NVDA   211.00 (-2.81%)
NIO   11.19 (-6.44%)
BABA   106.33 (-3.11%)
AMD   86.09 (-2.51%)
T   19.83 (-2.22%)
F   13.23 (-7.61%)
MU   62.41 (-1.20%)
CGC   2.92 (-7.01%)
GE   81.96 (-2.36%)
DIS   110.71 (-2.21%)
AMC   6.08 (+0.00%)
PFE   44.06 (-0.63%)
PYPL   85.52 (-1.66%)
NFLX   365.90 (-0.27%)
QQQ   306.18 (-1.78%)
AAPL   154.50 (+2.44%)
MSFT   258.35 (-2.36%)
META   186.53 (-1.19%)
GOOGL   104.78 (-2.75%)
AMZN   103.39 (-8.43%)
TSLA   189.98 (+0.91%)
NVDA   211.00 (-2.81%)
NIO   11.19 (-6.44%)
BABA   106.33 (-3.11%)
AMD   86.09 (-2.51%)
T   19.83 (-2.22%)
F   13.23 (-7.61%)
MU   62.41 (-1.20%)
CGC   2.92 (-7.01%)
GE   81.96 (-2.36%)
DIS   110.71 (-2.21%)
AMC   6.08 (+0.00%)
PFE   44.06 (-0.63%)
PYPL   85.52 (-1.66%)
NFLX   365.90 (-0.27%)
NASDAQ:CRON

Cronos Group - CRON Stock Forecast, Price & News

$2.49
-0.09 (-3.49%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.49
$2.57
50-Day Range
$2.42
$3.50
52-Week Range
$2.39
$4.31
Volume
1.53 million shs
Average Volume
1.53 million shs
Market Capitalization
$947.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.21

Cronos Group MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
69.2% Upside
$4.21 Price Target
Short Interest
Bearish
3.98% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.48mentions of Cronos Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$1.30 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.29) to ($0.19) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.87 out of 5 stars

Medical Sector

694th out of 1,029 stocks

Medicinals & Botanicals Industry

9th out of 15 stocks

CRON stock logo

About Cronos Group (NASDAQ:CRON) Stock

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

Altria Group Stock: Bull vs. Bear
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Cronos Group (NASDAQ:CRON) Sets New 52-Week Low at $2.39
Cronos Group Inc CRON Stock Quote
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Cryptocurrencies To Watch: Week of December 26
Equities Bruised Ahead of BoC Decision
Here's Why I'm Closing My Crypto.Com Account in 2023
Why Cardano, Chainlink, and Cronos Are Slumping Today
Matt Damon Crypto.com's Coin Is in Free Fall
Cronos Group: There Are Green Shoots Amid The Weeds
See More Headlines
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Company Calendar

Last Earnings
11/07/2022
Today
2/03/2023
Next Earnings (Estimated)
3/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CRON
Fax
N/A
Employees
626
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.21
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+69.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

Net Income
$-396,110,000.00
Net Margins
-235.72%
Pretax Margin
-234.01%

Debt

Sales & Book Value

Annual Sales
$74.43 million
Book Value
$3.56 per share

Miscellaneous

Free Float
357,838,000
Market Cap
$947.40 million
Optionable
Optionable
Beta
1.52

Key Executives

  • Michael Ryan GorensteinMichael Ryan Gorenstein
    Chairman, President & Chief Executive Officer
  • James Holm
    Chief Financial Officer
  • Arye Weigensberg
    Vice President-Research & Technology
  • Jeffrey Jacobson
    Senior VP, Head-Growth-North America
  • Shannon Buggy
    Senior Vice President & Global Head-People













CRON Stock - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CRON shares.
View CRON analyst ratings
or view top-rated stocks.

What is Cronos Group's stock price forecast for 2023?

7 Wall Street analysts have issued 12 month target prices for Cronos Group's shares. Their CRON share price forecasts range from $3.00 to $7.00. On average, they predict the company's share price to reach $4.21 in the next year. This suggests a possible upside of 65.3% from the stock's current price.
View analysts price targets for CRON
or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2023?

Cronos Group's stock was trading at $2.54 on January 1st, 2023. Since then, CRON shares have increased by 0.4% and is now trading at $2.55.
View the best growth stocks for 2023 here
.

When is Cronos Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our CRON earnings forecast
.

How were Cronos Group's earnings last quarter?

Cronos Group Inc. (NASDAQ:CRON) posted its earnings results on Monday, November, 7th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The business earned $20.92 million during the quarter, compared to analysts' expectations of $23.30 million. Cronos Group had a negative net margin of 235.72% and a negative trailing twelve-month return on equity of 16.29%.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI).

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Simplex Trading LLC (0.00%), Janney Montgomery Scott LLC (0.06%), National Bank of Canada FI (0.03%), Zurcher Kantonalbank Zurich Cantonalbank (0.01%), Bank of Montreal Can (0.00%) and Johnson & White Wealth Management LLC (0.00%). Insiders that own company stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham.
View institutional ownership trends
.

How do I buy shares of Cronos Group?

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $2.55.

How much money does Cronos Group make?

Cronos Group (NASDAQ:CRON) has a market capitalization of $970.22 million and generates $74.43 million in revenue each year. The company earns $-396,110,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.

How many employees does Cronos Group have?

The company employs 626 workers across the globe.

How can I contact Cronos Group?

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at (416) 504-0004.

This page (NASDAQ:CRON) was last updated on 2/3/2023 by MarketBeat.com Staff